Picture of Oncolys Biopharma logo

4588 — Oncolys Biopharma News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Table: Oncolys Biopharma -2018 parent results

Feb 8 (Reuters)- 
          Oncolys Biopharma Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended       Year ended       Year to       NEXT   
               Dec 31, 2018     Dec 31, 2017   Dec 31, 2019     YEAR     
                  LATEST          YEAR-AGO        COMPANY      COMPANY   
                 RESULTS          RESULTS        FORECAST    H1 FORECAST 
  Sales          168 mln          229 mln                                
               (-26.4 pct)      (+28.5 pct)                              
  Operating     loss 1.25        loss 1.08                               
  Recurring     loss 1.23        loss 1.09                               
  Net           loss 1.23        loss 1.09                               
  EPS        loss 104.55 yen  loss 106.23 yen                            
  Ann Div          NIL              NIL             NIL                  
  -Q2 Div          NIL              NIL             NIL                  
  -Q4 Div          NIL              NIL             NIL                  
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T

Recent news on Oncolys Biopharma

See all news